dr. siddiqi on the cll14 trial results in cll
Published 5 years ago • 242 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:10
dr. mato on the cll14 trial results in cll
-
1:12
dr. siddiqi on rationale for the transcend cll 004 trial in cll/sll
-
1:31
dr. shadman on the cll14 trial in cll
-
7:52
dr. siddiqi on liso-cel in the transcend cll 004 study
-
0:56
dr. al-sawaf on continual mrd assessment after venetoclax/obinutuzumab in cll
-
1:16
cll14: venetoclax-obinutuzumab improves pfs and mrd in untreated, reduced fitness cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
0:59
5-year follow-up results of cll14: obinutuzumab venetoclax vs obinutuzumab chlorambucil in cll
-
1:03
updates from the cll14 and cll2-give trials on cll
-
5:59
6-year results of cll14: venetoclax-obinutuzumab for previously untreated cll
-
0:46
dr. fakhri on tumor lysis syndrome associated with venetoclax/obinutuzumab in cll
-
7:10
the role of venetoclax rituximab in cll
-
1:58
dr. eradat on the captivate trial in cll
-
4:30
cll14 trial: obinutuzumab venetoclax vs obinutuzumab chlorambucil
-
1:02
dr. gerson on venetoclax/obinutuzumab combination in cll
-
1:31
dr. smith on the rationale behind the fixed duration trial for ibrutinib/venetoclax in cll
-
9:15
obinutuzumab venetoclax for frontline cll
-
1:01
dr. abedin on the role of venetoclax plus obinutuzumab in cll
-
1:57
dr. wierda on chemoimmunotherapy in cll